Sales of Merck’s MRK second-largest product, Gardasil, which is a vaccine approved to prevent certain cancers caused by the ...

Gardasil is Merck & Co.’s (MRK) leading vaccine franchise. Gardasil is a vaccine for the prevention of certain strains of HPV (human papillomavirus), a sexually transmitted disease. Total sales of ...

Robert F. Kennedy Jr. and a group of personal injury lawyers have long accused Merck & Co. of “disease mongering” to boost ...

While clicking through Snapchat the other day, an ad for Merck’s new Versed campaign for Gardasil, its vaccine against the human papillomavirus (HPV), stopped my thumb in its tracks. As a researcher ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The FDA has approved Gardasil, a vaccine that targets the virus responsible for most cervical cancers and genital warts. Here are 12 questions and answers on the new vaccine. 1. What is Gardasil?

The nine-valent HPV vaccine, Gardasil 9, showed long-term effectiveness in preventing cervical cancer cases, according to a study published in The Lancet. The FDA approved Gardasil 9 in 2014. The ...

In 2006, the Food and Drug Administration (“FDA”) approved the use of Gardasil for females 9-26 years old to protect against certain cancers caused by human papillomavirus (“HPV”). However, in the ...

Merck & Co. won’t be able to fully meet global demand for HPV vaccine Gardasil until after 2023 when it completes production of a couple of manufacturing plants. So for now, the drugmaker is again ...

Merck HPV vaccine Gardasil is poised for major growth by 2025 as new geographies and expanded labels add more people to its patient pool. Although the vaccine is 12 years old, Wolfe Research analysts ...

Gardasil is a vaccination that is being used routinely in males and females aged around 9 to 12 years, before they become sexually active. Gardasil offers protection against human papillomma virus ...

Neal Fowler, 50, the chief executive officer of a tiny biotech called ­Liquidia, was assuming a position common to road-warrior entrepreneurs: leaning his elbows on the seat-back tray in an airplane ...